1. |
Antibacterials: best attack in penetrating head injuries? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1239,
2000,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
2. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1239,
2000,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
3. |
Willingness to pay for paclitaxel in NZ |
|
Inpharma Weekly,
Volume &NA;,
Issue 1239,
2000,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
4. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1239,
2000,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
5. |
News from the 91st Annual Meeting of the American Association for Cancer ResearchSan Francisco, US April 2000 |
|
Inpharma Weekly,
Volume &NA;,
Issue 1239,
2000,
Page 6-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
6. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1239,
2000,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
7. |
Prasterone restores cardiac and hepatocellular functions |
|
Inpharma Weekly,
Volume &NA;,
Issue 1239,
2000,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
8. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1239,
2000,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
9. |
Who benefits from adjuvant therapy in colorectal cancer? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1239,
2000,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
10. |
Where to now with hormonal therapy in prostate cancer? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1239,
2000,
Page 11-12
Robert Carlson,
Preview
|
|
摘要:
Hormonal ablation has been an accepted treatment for prostate cancer for more than a century, first through surgical orchiectomy, then through estrogen therapy. Nonsteroidal antiandrogens and gonadotropin releasing hormone (GnRH) analogues had their debut in the 1980s, followed by the 5α-reductase inhibitors and ketoconazole, and in the 1990s, high-dose antiandrogens. But orchiectomy is still the gold standard of hormonal management, a modality that is making a comeback as the comparator for some of the newer treatments. And while androgen ablation is important for improving local control before surgery or radiotherapy, lengthening survival times in advanced disease and providing palliation in patients with metastases, few patients achieve complete responses and there is a continued risk of death over time.'There is no plateau to the[mortality]curve',is how 1 speaker phrased the situation at the 95th Annual Meeting of the American Urological Association (AUA) [Atlanta, US; April-May 2000].
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|